Add BrightSurf on Google Email

Research opens up new avenue for Tuberculosis drug discovery

Scientists from the University of Bath have identified two new families of chemical compounds that inhibit alpha-methylacyl-CoA racemase (MCR) in Mycobacterium tuberculosis, a key enzyme for TB survival. This breakthrough could lead to new treatments for TB and potentially other diseases like prostate cancer.

SourceUniversity of Bath·JournalJournal of Biological Chemistry·TypeExperimental study·DateJul 2, 2025

How a crucial DNA repair protein works—and what it means for cancer treatment

Researchers at Scripps Research have captured the first detailed images of polymerase theta (Pol-theta) in action, revealing its molecular processes responsible for a range of cancers. The study provides a blueprint for designing more effective cancer drugs by understanding how Pol-theta repairs DNA using a two-step process.

SourceScripps Research Institute·JournalNature Structural & Molecular Biology·DateMar 3, 2025

Splicing twins: unravelling the secrets of the minor spliceosome complex

Researchers in the Galej Group at EMBL Grenoble have provided new structural insights into the U11 snRNP subunit of the minor spliceosome, revealing its ability to specifically identify rare substrates. The study sheds light on the complex assembly pathway of the minor spliceosome, which is critical for processing minor introns in genes.

SourceEuropean Molecular Biology Laboratory·JournalMolecular Cell·TypeExperimental study·DateFeb 12, 2025

Glycans can regulate their own biosynthesis by modifying enzyme activity

Researchers found that glycans attached to glycosylation enzymes' lectin domains inhibit the enzymes' activity, leading to self-regulation of their own biosynthesis. This unique mechanism sheds light on how glycosylation enzymes choose their substrate proteins in cells.

Catching prey with grappling hooks and cannons

Researchers at ETH Zurich have discovered a new predatory bacterium, Aureispira, that uses grappling hooks and cannons to capture prey. The bacterium's molecular structures resemble those of pirate tools, allowing it to entangle and kill its victims quickly.

SourceETH Zurich·JournalScience·DateOct 17, 2024

Putting out a brain on fire

Researchers have made a breakthrough in understanding the rare autoimmune disease anti-NMDAR encephalitis, which can cause psychosis, hallucinations, and blackouts. The study found that different antibodies bind to NMDA receptors in unique ways, suggesting personalized medicine may be key to treating the condition.

SourceCold Spring Harbor Laboratory·JournalNature Structural & Molecular Biology·DateOct 17, 2024

Scientists from IOCB Prague help to improve medical drugs

Researchers at IOCB Prague successfully isolated the proteasome enzyme complex of the T. vaginalis parasite, enabling them to develop new medicines that can target this parasite without harming humans. This breakthrough has critical implications for treating trichomoniasis and reducing HIV risk.

Protein mutant stability can be inferred from AI-predicted structures

Researchers used AlphaFold2 to predict structural effects of mutations on protein stability, finding correlations between small structural changes and stability changes. This breakthrough opens up new possibilities for protein engineering, enabling scientists to design proteins with specific functions more effectively.

SourceInstitute for Basic Science·JournalPhysical Review Letters·TypeComputational simulation/modeling·DateAug 28, 2024

Kamikaze termites protect their colony with the help of a special enzyme. Its secrets have been uncovered by scientists from IOCB Prague

Researchers from IOCB Prague uncover the mechanism behind a unique termite defense, where worker termites sacrifice themselves to kill attackers. The discovery sheds light on the enzyme's durability and functionality in harsh conditions.

How plants become bushy, or not

A new study from the University of California, Davis, reveals how plants break down the hormone strigolactone to become more bushy. The researchers found that enzymes called carboxylesterases play a crucial role in degrading strigolactone, and identified specific amino acids that allow these enzymes to bind to the hormone.

SourceUniversity of California - Davis·JournalNature Communications·TypeExperimental study·DateAug 6, 2024

This protein does “The Twist”

Researchers have identified the critical step in NMDAR's routine where it rotates into an open formation, enabling electrical signals crucial for cognitive functions. This discovery may pave the way for drug compounds that can correct faulty NMDARs, potentially treating conditions like Alzheimer's and depression.

Slipping a note to a neighbor: The cellular way

Researchers from PSI and ETH Zurich studied connexin-36 gap junction channels and found that antimalarial drug mefloquine binds to the channels, potentially explaining its severe side effects. The study provides new insights into how drugs interact with connexins and may lead to the development of therapies for neurological diseases.

SourcePaul Scherrer Institute·JournalCell Discovery·TypeExperimental study·DateJun 26, 2024

An enzyme with a smart friend

Researchers discovered that enzyme METTL6 interacts with tRNA synthetase to recognize specific tRNAs, enabling precise modification and potential application in cancer treatment. This discovery provides new insights into the molecular machinery of protein production.

SourceEuropean Molecular Biology Laboratory·JournalNature Structural & Molecular Biology·TypeExperimental study·DateJun 25, 2024

Researchers observe the structural heterogeneity of a lipid scramblase

TMEM16F, a transmembrane protein, exhibits a wide range of structural conformations that enable its diverse functions. The study reveals unexpected changes in dimerization interface and subunit arrangements, suggesting a dynamic and versatile mechanism for lipid scrambling and ion movement across the cell membrane.

SourceNano Life Science Institute (NanoLSI), Kanazawa University·JournalNature Communications·TypeExperimental study·DateFeb 20, 2024

Introducing Cresomycin, a synthetic antimicrobial molecule highly effective against multidrug-resistant bacteria

Researchers developed cresomycin, a conformally restricted antibiotic molecule that optimizes for ribosomal binding, inhibiting Gram-negative and positive bacteria, including multi-drug resistant strains. The findings portend favorably for the future discovery of antibacterial agents broadly effective against antimicrobial resistance.

Spying on a shape-shifting protein

Scientists at the Advanced Science Research Center used X-ray crystallography with elevated temperature and pressure to observe distinct shapes in a protein molecule. The study reveals how proteins change shape to bind metabolites or other proteins, offering insight into disease treatment and development of novel drugs.

SourceAdvanced Science Research Center, GC/CUNY·JournalCommunications Biology·TypeImaging analysis·DateJan 12, 2024

Scientists in Germany develop a new analytical method, which enables improved insight into (mRNA) nanoparticles and similar pharmaceutical and non-pharmaceutical products

Scientists in Germany developed a new analytical method to precisely elucidate the size of particles, structure, and RNA molecules in pharmaceutical products. This information can help evaluate product quality, enabling improved development of new products.

SourceEuropean Molecular Biology Laboratory·JournalScientific Reports·TypeExperimental study·DateDec 19, 2023

How marine bristle worms use a special protein to distinguish between sunlight and moonlight

Researchers at Johannes Gutenberg University Mainz discovered a unique cryptochrome protein in marine bristle worms that distinguishes between sunlight and moonlight. The protein's structure reveals an unusual light-induced change from dimer to monomer arrangements, allowing it to synchronize reproduction with lunar phases.

SourceJohannes Gutenberg Universitaet Mainz·JournalNature Communications·DateNov 13, 2023

Revealing structural secrets of a key cancer protein

Scientists have discovered two 'switch' regions in the structure of the K-Ras protein that are affected by dangerous mutations. These regions, located near a protein loop, can amplify cell division and lead to cancer. Researchers say their findings provide new insights into the mechanisms of these mutations and potential drug targets.

SourceOhio State University·JournalNature Structural & Molecular Biology·DateOct 18, 2023

Tiny CRISPR tool could help shred viruses

Rice University scientists developed a tiny CRISPR-Cas13 system to shred viruses by targeting RNA. The system's unique mechanism and three-dimensional structure were mapped using cryo-electron microscopy, allowing researchers to engineer it for improved precision and specificity.

SourceRice University·JournalNature Communications·TypeExperimental study·DateSep 27, 2023

Scaling up the power of nanotechnology

The team created a proof-of-concept nanocapsule capable of delivering specific payloads to targeted locations, with potential applications in drug delivery, nutrient transport, and other fields. By using calcium metal ions as building blocks, they can generate identical reservoirs for different substances.

SourceUniversity of Missouri-Columbia·JournalChemical Science·DateSep 21, 2023

How plants pass down genetic memories

Researchers have discovered how plants pass along chemical markers that instruct cells on using DNA codes, a process known as epigenetic inheritance. The study reveals the role of protein DDM1 in making way for enzymes that add regulatory marks to new DNA strands, preserving genetic controls across generations.

An escape signal for the nematode: Artificial intelligence helps elucidate structure of a novel light sensor

A team of scientists has successfully elucidated the structure and function of LITE-1, a biomolecule used by Caenorhabditis elegans to detect danger. The researchers used artificial intelligence to predict the structure of LITE-1, which is a channel protein that forms a pore in the cell membrane allowing charged particles to pass through.

SourceGoethe University Frankfurt·JournalCurrent Biology·TypeExperimental study·DateAug 2, 2023